Condensed Consolidated Statement of Changes in Shareholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock	Preferred Stock	Common Stock Issuable	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2019	$ 10,990		$ 159,538	$ 13,016,446	$ (16,029,654)	$ (2,842,680)
Balance (in Shares) at Dec. 31, 2019	109,894,490
Sales of common stock	$ 419		(59,000)	407,181		348,600
Sales of common stock (in Shares)	4,187,566
Fair value of warrants allocated to proceeds of common stock				88,833		88,833
Conversion of convertible notes payable to common stock	$ 467		51,652	600,441		652,560
Conversion of convertible notes payable to common stock (in Shares)	4,672,612
Consultant and director fees payable with common shares and warrants			60,212	6,666		66,878
Shares and options issued pursuant to employee equity incentive plan	$ 13		(7,161)	45,724		38,576
Shares and options issued pursuant to employee equity incentive plan (in Shares)	132,500
Net loss					(580,216)	(580,216)
Balance at Mar. 31, 2020	$ 11,889		205,241	14,165,291	(16,609,870)	(2,227,449)
Balance (in Shares) at Mar. 31, 2020	118,887,168
Acquisition of Cura Health Management LLC	$ 224			201,451		201,675
Acquisition of Cura Health Management LLC (in Shares)	2,240,838
Sales of common stock	$ 318		24,651	228,808		253,777
Sales of common stock (in Shares)	3,180,312
Fair value of warrants allocated to proceeds of common stock				33,482		33,482
Conversion of convertible notes payable to common stock	$ 667		(51,652)	584,268		533,283
Conversion of convertible notes payable to common stock (in Shares)	6,669,320
Consultant and director fees payable with common shares and warrants	$ 11		34,705	8,989		43,705
Consultant and director fees payable with common shares and warrants (in Shares)	111,110
Shares and options issued pursuant to employee equity incentive plan	$ 16			39,397		39,413
Shares and options issued pursuant to employee equity incentive plan (in Shares)	163,027
Net loss					(1,517,848)	(1,517,848)
Balance at Jun. 30, 2020	$ 13,125		212,945	15,261,686	(18,127,718)	(2,639,962)
Balance (in Shares) at Jun. 30, 2020	131,251,775
Sales of common stock	$ 483		(23,901)	340,582		317,164
Sales of common stock (in Shares)	4,829,289
Contingent acquisition consideration issuable	$ 184			292,599		292,783
Contingent acquisition consideration issuable (in Shares)	1,835,626
Sale of common and preferred stock in exchange for marketable securities	$ 2,452	$ 2,750		3,061,687		3,066,889
Sale of common and preferred stock in exchange for marketable securities (in Shares)	24,522,727	2,750,000
Gain on extinguishment of related party debt allocated to additional paid in capital				283,862		283,862
Fair value of warrants allocated to proceeds of common stock				57,444		57,444
Conversion of convertible notes payable to common stock	$ 286			479,387		479,673
Conversion of convertible notes payable to common stock (in Shares)	2,855,191
Consultant and director fees payable with common shares and warrants	$ 100		(6,952)	136,611		129,759
Consultant and director fees payable with common shares and warrants (in Shares)	1,003,751
Shares and options issued pursuant to employee equity incentive plan	$ 53			98,448		98,501
Shares and options issued pursuant to employee equity incentive plan (in Shares)	529,465
Net loss					(1,734,295)	(1,734,295)
Balance at Sep. 30, 2020	$ 16,683	$ 2,750	182,092	20,012,306	(19,862,013)	351,818
Balance (in Shares) at Sep. 30, 2020	166,827,824	2,750,000
Balance at Dec. 31, 2020	$ 18,797	$ 2,750	262,273	22,851,098	(21,784,910)	1,350,008
Balance (in Shares) at Dec. 31, 2020	187,967,881	2,750,000
Sales of common stock	$ 1,479			2,981,367		2,982,846
Sales of common stock (in Shares)	14,793,864
Fair value of warrants allocated to proceeds of common stock				1,406,515		1,406,515
Conversion of convertible notes payable to common stock	$ 1,354			4,060,194		4,061,548
Conversion of convertible notes payable to common stock (in Shares)	13,538,494
Fair value of warrants issued in connection with conversion and retirement of convertible notes payable				3,201,138		3,201,138
Fair value of warrants issued for professional services				32,426		32,426
Consultant and director fees payable with common shares and warrants	$ 48		114,500	122,781		237,329
Consultant and director fees payable with common shares and warrants (in Shares)	475,000
Shares and options issued pursuant to employee equity incentive plan	$ 24		(14,956)	52,337		37,405
Shares and options issued pursuant to employee equity incentive plan (in Shares)	240,310
Exercise of stock warrants	$ 905		62,500	613,316		676,721
Exercise of stock warrants (in Shares)	9,047,332
Exercise of stock options	$ 1			3,149		3,150
Exercise of stock options (in Shares)	12,500
Net loss					(7,823,453)	(7,823,453)
Balance at Mar. 31, 2021	$ 22,608	$ 2,750	424,317	35,324,321	(29,608,363)	6,165,633
Balance (in Shares) at Mar. 31, 2021	226,075,381	2,750,000
Sales of common stock	$ 37			177,642		177,679
Sales of common stock (in Shares)	374,177
Fair value of warrants allocated to proceeds of common stock				82,320		82,320
Fair value of warrants issued for professional services				3,603		3,603
Fair value of warrants issued for professional services (in Shares)
Consultant and director fees payable with common shares and warrants	$ 9		68,807	17,990		86,806
Consultant and director fees payable with common shares and warrants (in Shares)	93,492
Shares and options issued pursuant to employee equity incentive plan	$ 88		(147,791)	211,358		63,655
Shares and options issued pursuant to employee equity incentive plan (in Shares)	875,047
Exercise of stock warrants	$ 123		62,500	152,378		215,001
Exercise of stock warrants (in Shares)	1,225,000
Exercise of stock options	$ 13			13,287		13,300
Exercise of stock options (in Shares)	133,000
Net loss					(505,764)	(505,764)
Balance at Jun. 30, 2021	$ 22,878	$ 2,750	407,833	35,982,899	(30,114,127)	6,302,233
Balance (in Shares) at Jun. 30, 2021	228,776,097	2,750,000
Sales of common stock	$ 470			1,608,874		1,609,344
Sales of common stock (in Shares)	4,703,704
Contingent acquisition consideration issuable			366,300			366,300
Fair value of warrants allocated to proceeds of common stock				690,577		690,577
Fair value of warrants issued for professional services				3,603		3,603
Consultant and director fees payable with common shares and warrants	$ 1		84,785	4,942		89,728
Consultant and director fees payable with common shares and warrants (in Shares)	8,750
Shares and options issued pursuant to employee equity incentive plan	$ 37		(5,550)	25,955		20,442
Shares and options issued pursuant to employee equity incentive plan (in Shares)	375,000
Exercise of stock warrants	$ 184		(125,000)	181,066		56,250
Exercise of stock warrants (in Shares)	1,840,278
Net loss					(368,017)	(368,017)
Balance at Sep. 30, 2021	$ 23,570	$ 2,750	$ 728,368	$ 38,497,916	$ (30,482,144)	$ 8,770,460
Balance (in Shares) at Sep. 30, 2021	235,703,829	2,750,000